[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2158401A - Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained - Google Patents

Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained

Info

Publication number
AU2158401A
AU2158401A AU21584/01A AU2158401A AU2158401A AU 2158401 A AU2158401 A AU 2158401A AU 21584/01 A AU21584/01 A AU 21584/01A AU 2158401 A AU2158401 A AU 2158401A AU 2158401 A AU2158401 A AU 2158401A
Authority
AU
Australia
Prior art keywords
formulation
lipophilicity
solubility
substances
low water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21584/01A
Inventor
Koert Nico Jan Burger
Ben De Kruijff
Rutger Willibrordes Henricus Maria Staffhorst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seed Capital Investments (SCI) BV
Original Assignee
SEED CAPITAL INVESTMENT 2 SCI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SEED CAPITAL INVESTMENT 2 SCI filed Critical SEED CAPITAL INVESTMENT 2 SCI
Publication of AU2158401A publication Critical patent/AU2158401A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU21584/01A 1999-11-05 2000-11-06 Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained Abandoned AU2158401A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99203673 1999-11-05
EP99203673 1999-11-05
PCT/EP2000/011236 WO2001032139A2 (en) 1999-11-05 2000-11-06 Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained

Publications (1)

Publication Number Publication Date
AU2158401A true AU2158401A (en) 2001-05-14

Family

ID=8240830

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21584/01A Abandoned AU2158401A (en) 1999-11-05 2000-11-06 Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained

Country Status (5)

Country Link
EP (1) EP1225871A2 (en)
JP (1) JP2003513030A (en)
AU (1) AU2158401A (en)
CA (1) CA2389147A1 (en)
WO (1) WO2001032139A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003260239A1 (en) * 2002-06-26 2004-01-19 Tuo Jin Solid dosage forms for rapid dissolution of poorly soluble drugs
US9186322B2 (en) 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
FR2924430B1 (en) * 2007-11-30 2010-03-19 Univ Bordeaux 2 PROCESS FOR THE PREPARATION OF NANOPARTICLES BASED ON FUNCTIONAL AMPHIPHILIC MOLECULES OR MACROMOLECULES AND THEIR USE
FR2945946B1 (en) 2009-05-29 2011-08-26 Univ Victor Segalen Bordeaux 2 MULTI-COMPARTMENT FORMULATIONS BASED ON FUNCTIONAL AMPHIPHILIC MOLECULES OR MACROMOLECULES
CN115414384A (en) 2012-09-04 2022-12-02 埃莱森制药有限责任公司 Prevention of pulmonary recurrence of cancer with cisplatin lipid complexes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736155A (en) * 1984-08-08 1998-04-07 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
DE4341472A1 (en) * 1993-12-02 1995-06-08 Schering Ag A method for increasing the stability of liposome suspensions containing hydrophilic drugs

Also Published As

Publication number Publication date
WO2001032139A2 (en) 2001-05-10
CA2389147A1 (en) 2001-05-10
JP2003513030A (en) 2003-04-08
EP1225871A2 (en) 2002-07-31
WO2001032139A3 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
AU6111699A (en) Novel method and compounds
AU4363300A (en) Ultrasound for autocapture or other applications
AU2002212258A1 (en) Assembly and method for the optical-tactile measurement of a structure
AU7989400A (en) Compounds and methods
AU3664899A (en) Substrate sensor
AU3734799A (en) 5-demethoxyfumagillol derivatives and processes for preparing the same
AU3215500A (en) Compounds and methods
AU3763299A (en) Supramolecular structures and process for making the same
AU6040299A (en) Jacking screw
AU2186501A (en) Dynamic deviation
AUPP650198A0 (en) Cement formulation
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
AU2158401A (en) Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained
AU2333099A (en) Aryloxyanilides and related compounds
AU6480299A (en) Pharmaceutical compounds
AU6228299A (en) 2-substituted-d-homooxasteroid derivatives
AU2207001A (en) Novel compounds and process
AU6121200A (en) Janus trailer
AU5115800A (en) An underreamer and a method of using the underreamer
AU2640999A (en) 1-azaindolizine derivatives
AU4821899A (en) A process for the preparation of macrocyclic metalloprotease inhibitors
AU5182099A (en) Pharmaceutical formulation
AU5184599A (en) Pharmaceutical compounds
AU2894099A (en) Phenanthrofuran derivatives
AU4141099A (en) Pyrazolyldioxothiochromanoyl derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase